Vanguard Capital Management’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
Other funds holding SLDB
SL
Vanguard Capital Management's SLDB Position: Q3 2026 in Review
Vanguard Capital Management reduced its Solid Biosciences (SLDB) stake by 1% in Q3 2026, selling an estimated $380K and leaving 3,967,899 shares worth $28.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2201.
Vanguard Capital Management first reported a position in SLDB in Q1 2026 and has held it in 3 quarters since. The position peaked at $40.1M in Q2 2026. 158 funds tracked by Wall St. Rank hold SLDB as of Q3 2026.
- Vanguard Capital Management held 3,967,899 shares of Solid Biosciences worth $28.7M as of Q3 2026.
- Vanguard Capital Management sold 42,023 Solid Biosciences shares in Q3 2026, an estimated $380K.
- Solid Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2201 holding.
- Vanguard Capital Management first reported a position in Solid Biosciences in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Solid Biosciences position peaked at $40.1M in Q2 2026.
- 158 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.